Sponsor Pipeline

Dr. David Wasserstein Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT07036003
Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)		 Enrollment closed, study ongoing
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07036003 Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR) Knee Osteoarthritis (Knee OA) Active, Not Recruiting
Get alerts when Dr. David Wasserstein's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free